カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

世界のハイパー免疫グロブリン市場2022年：市場規模予測（～2028年）

■ 英語タイトル：Global Hyper Immune Globulin Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR22NO17909）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR22NO17909
■ 発行日：2022年11月（※2025年版があります。お問い合わせください。）
■ 調査対象地域：グローバル
■ 産業分野：医療機器
■ ページ数：100
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[世界のハイパー免疫グロブリン市場2022年：市場規模予測（～2028年）]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

ハイパー免疫グロブリン市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界のハイパー免疫グロブリンの市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

ハイパー免疫グロブリン市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・B型肝炎免疫グロブリン、狂犬病免疫グロブリン、破傷風免疫グロブリン、Rho(D)免疫グロブリン、その他

用途別セグメントは次のように区分されます。
・政府、民間、その他

世界のハイパー免疫グロブリン市場の主要な市場プレーヤーは以下のとおりです。
・CSL Behring、Grifols、Biotest、Kedrion、CBPO、Emergent (Cangene)、Kamada、CNBG、Hualan Bio、Shanghai RAAS、Sichuan Yuanda Shuyang、ADMA Biologics

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、ハイパー免疫グロブリン製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要なハイパー免疫グロブリンメーカーの企業概要、2019年～2022年までのハイパー免疫グロブリンの価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要なハイパー免疫グロブリンメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別ハイパー免疫グロブリンの販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までのハイパー免疫グロブリンの種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域でのハイパー免疫グロブリン市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、およびハイパー免疫グロブリンの産業チェーンを掲載しています。
・第13、14、15章では、ハイパー免疫グロブリンの販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
- ハイパー免疫グロブリンの概要
- 種類別分析（2017年vs2021年vs2028年）：B型肝炎免疫グロブリン、狂犬病免疫グロブリン、破傷風免疫グロブリン、Rho(D)免疫グロブリン、その他
- 用途別分析（2017年vs2021年vs2028年）：政府、民間、その他
- 世界のハイパー免疫グロブリン市場規模・予測
- 世界のハイパー免疫グロブリン生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
- CSL Behring、Grifols、Biotest、Kedrion、CBPO、Emergent (Cangene)、Kamada、CNBG、Hualan Bio、Shanghai RAAS、Sichuan Yuanda Shuyang、ADMA Biologics
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：B型肝炎免疫グロブリン、狂犬病免疫グロブリン、破傷風免疫グロブリン、Rho(D)免疫グロブリン、その他
・用途別分析2017年-2028年：政府、民間、その他
・ハイパー免疫グロブリンの北米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：アメリカ、カナダ、メキシコなど
・ハイパー免疫グロブリンのヨーロッパ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・ハイパー免疫グロブリンのアジア市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・ハイパー免疫グロブリンの南米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ブラジル、アルゼンチンなど
・ハイパー免疫グロブリンの中東・アフリカ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Hyper Immune Globulin market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Hyper Immune Globulin market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Government Institutions accounting for % of the Hyper Immune Globulin global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Hepatitis B Immunoglobulins segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Hyper Immune Globulin include CSL Behring, Grifols, Biotest, Kedrion, and CBPO, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Hyper Immune Globulin market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Hepatitis B Immunoglobulins
Rabies Immunoglobulins
Tetanus Immunoglobulins
Rho(D) Immunoglobulins
Others
Market segment by Application can be divided into
Government Institutions
Private Sector
Others
The key market players for global Hyper Immune Globulin market are listed below:
CSL Behring
Grifols
Biotest
Kedrion
CBPO
Emergent (Cangene)
Kamada
CNBG
Hualan Bio
Shanghai RAAS
Sichuan Yuanda Shuyang
ADMA Biologics
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Hyper Immune Globulin product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Hyper Immune Globulin, with price, sales, revenue and global market share of Hyper Immune Globulin from 2019 to 2022.
Chapter 3, the Hyper Immune Globulin competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Hyper Immune Globulin breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Hyper Immune Globulin market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Hyper Immune Globulin.
Chapter 13, 14, and 15, to describe Hyper Immune Globulin sales channel, distributors, customers, research findings and conclusion, appendix and data source.

*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Hyper Immune Globulin Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Hyper Immune Globulin Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Hepatitis B Immunoglobulins
1.2.3 Rabies Immunoglobulins
1.2.4 Tetanus Immunoglobulins
1.2.5 Rho(D) Immunoglobulins
1.2.6 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Hyper Immune Globulin Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Government Institutions
1.3.3 Private Sector
1.3.4 Others
1.4 Global Hyper Immune Globulin Market Size & Forecast
1.4.1 Global Hyper Immune Globulin Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Hyper Immune Globulin Sales in Volume (2017-2028)
1.4.3 Global Hyper Immune Globulin Price (2017-2028)
1.5 Global Hyper Immune Globulin Production Capacity Analysis
1.5.1 Global Hyper Immune Globulin Total Production Capacity (2017-2028)
1.5.2 Global Hyper Immune Globulin Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Hyper Immune Globulin Market Drivers
1.6.2 Hyper Immune Globulin Market Restraints
1.6.3 Hyper Immune Globulin Trends Analysis
2 Manufacturers Profiles
2.1 CSL Behring
2.1.1 CSL Behring Details
2.1.2 CSL Behring Major Business
2.1.3 CSL Behring Hyper Immune Globulin Product and Services
2.1.4 CSL Behring Hyper Immune Globulin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Grifols
2.2.1 Grifols Details
2.2.2 Grifols Major Business
2.2.3 Grifols Hyper Immune Globulin Product and Services
2.2.4 Grifols Hyper Immune Globulin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Biotest
2.3.1 Biotest Details
2.3.2 Biotest Major Business
2.3.3 Biotest Hyper Immune Globulin Product and Services
2.3.4 Biotest Hyper Immune Globulin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Kedrion
2.4.1 Kedrion Details
2.4.2 Kedrion Major Business
2.4.3 Kedrion Hyper Immune Globulin Product and Services
2.4.4 Kedrion Hyper Immune Globulin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 CBPO
2.5.1 CBPO Details
2.5.2 CBPO Major Business
2.5.3 CBPO Hyper Immune Globulin Product and Services
2.5.4 CBPO Hyper Immune Globulin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Emergent (Cangene)
2.6.1 Emergent (Cangene) Details
2.6.2 Emergent (Cangene) Major Business
2.6.3 Emergent (Cangene) Hyper Immune Globulin Product and Services
2.6.4 Emergent (Cangene) Hyper Immune Globulin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Kamada
2.7.1 Kamada Details
2.7.2 Kamada Major Business
2.7.3 Kamada Hyper Immune Globulin Product and Services
2.7.4 Kamada Hyper Immune Globulin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 CNBG
2.8.1 CNBG Details
2.8.2 CNBG Major Business
2.8.3 CNBG Hyper Immune Globulin Product and Services
2.8.4 CNBG Hyper Immune Globulin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Hualan Bio
2.9.1 Hualan Bio Details
2.9.2 Hualan Bio Major Business
2.9.3 Hualan Bio Hyper Immune Globulin Product and Services
2.9.4 Hualan Bio Hyper Immune Globulin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Shanghai RAAS
2.10.1 Shanghai RAAS Details
2.10.2 Shanghai RAAS Major Business
2.10.3 Shanghai RAAS Hyper Immune Globulin Product and Services
2.10.4 Shanghai RAAS Hyper Immune Globulin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Sichuan Yuanda Shuyang
2.11.1 Sichuan Yuanda Shuyang Details
2.11.2 Sichuan Yuanda Shuyang Major Business
2.11.3 Sichuan Yuanda Shuyang Hyper Immune Globulin Product and Services
2.11.4 Sichuan Yuanda Shuyang Hyper Immune Globulin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 ADMA Biologics
2.12.1 ADMA Biologics Details
2.12.2 ADMA Biologics Major Business
2.12.3 ADMA Biologics Hyper Immune Globulin Product and Services
2.12.4 ADMA Biologics Hyper Immune Globulin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Hyper Immune Globulin Breakdown Data by Manufacturer
3.1 Global Hyper Immune Globulin Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Hyper Immune Globulin Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Hyper Immune Globulin
3.4 Market Concentration Rate
3.4.1 Top 3 Hyper Immune Globulin Manufacturer Market Share in 2021
3.4.2 Top 6 Hyper Immune Globulin Manufacturer Market Share in 2021
3.5 Global Hyper Immune Globulin Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Hyper Immune Globulin Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Hyper Immune Globulin Market Size by Region
4.1.1 Global Hyper Immune Globulin Sales in Volume by Region (2017-2028)
4.1.2 Global Hyper Immune Globulin Revenue by Region (2017-2028)
4.2 North America Hyper Immune Globulin Revenue (2017-2028)
4.3 Europe Hyper Immune Globulin Revenue (2017-2028)
4.4 Asia-Pacific Hyper Immune Globulin Revenue (2017-2028)
4.5 South America Hyper Immune Globulin Revenue (2017-2028)
4.6 Middle East and Africa Hyper Immune Globulin Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Hyper Immune Globulin Sales in Volume by Type (2017-2028)
5.2 Global Hyper Immune Globulin Revenue by Type (2017-2028)
5.3 Global Hyper Immune Globulin Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Hyper Immune Globulin Sales in Volume by Application (2017-2028)
6.2 Global Hyper Immune Globulin Revenue by Application (2017-2028)
6.3 Global Hyper Immune Globulin Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Hyper Immune Globulin Sales by Type (2017-2028)
7.2 North America Hyper Immune Globulin Sales by Application (2017-2028)
7.3 North America Hyper Immune Globulin Market Size by Country
7.3.1 North America Hyper Immune Globulin Sales in Volume by Country (2017-2028)
7.3.2 North America Hyper Immune Globulin Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Hyper Immune Globulin Sales by Type (2017-2028)
8.2 Europe Hyper Immune Globulin Sales by Application (2017-2028)
8.3 Europe Hyper Immune Globulin Market Size by Country
8.3.1 Europe Hyper Immune Globulin Sales in Volume by Country (2017-2028)
8.3.2 Europe Hyper Immune Globulin Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Hyper Immune Globulin Sales by Type (2017-2028)
9.2 Asia-Pacific Hyper Immune Globulin Sales by Application (2017-2028)
9.3 Asia-Pacific Hyper Immune Globulin Market Size by Region
9.3.1 Asia-Pacific Hyper Immune Globulin Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Hyper Immune Globulin Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Hyper Immune Globulin Sales by Type (2017-2028)
10.2 South America Hyper Immune Globulin Sales by Application (2017-2028)
10.3 South America Hyper Immune Globulin Market Size by Country
10.3.1 South America Hyper Immune Globulin Sales in Volume by Country (2017-2028)
10.3.2 South America Hyper Immune Globulin Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Hyper Immune Globulin Sales by Type (2017-2028)
11.2 Middle East & Africa Hyper Immune Globulin Sales by Application (2017-2028)
11.3 Middle East & Africa Hyper Immune Globulin Market Size by Country
11.3.1 Middle East & Africa Hyper Immune Globulin Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Hyper Immune Globulin Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Hyper Immune Globulin and Key Manufacturers
12.2 Manufacturing Costs Percentage of Hyper Immune Globulin
12.3 Hyper Immune Globulin Production Process
12.4 Hyper Immune Globulin Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Hyper Immune Globulin Typical Distributors
13.3 Hyper Immune Globulin Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Hyper Immune Globulin Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Hyper Immune Globulin Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. CSL Behring Basic Information, Manufacturing Base and Competitors
Table 4. CSL Behring Major Business
Table 5. CSL Behring Hyper Immune Globulin Product and Services
Table 6. CSL Behring Hyper Immune Globulin Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Grifols Basic Information, Manufacturing Base and Competitors
Table 8. Grifols Major Business
Table 9. Grifols Hyper Immune Globulin Product and Services
Table 10. Grifols Hyper Immune Globulin Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Biotest Basic Information, Manufacturing Base and Competitors
Table 12. Biotest Major Business
Table 13. Biotest Hyper Immune Globulin Product and Services
Table 14. Biotest Hyper Immune Globulin Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Kedrion Basic Information, Manufacturing Base and Competitors
Table 16. Kedrion Major Business
Table 17. Kedrion Hyper Immune Globulin Product and Services
Table 18. Kedrion Hyper Immune Globulin Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. CBPO Basic Information, Manufacturing Base and Competitors
Table 20. CBPO Major Business
Table 21. CBPO Hyper Immune Globulin Product and Services
Table 22. CBPO Hyper Immune Globulin Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Emergent (Cangene) Basic Information, Manufacturing Base and Competitors
Table 24. Emergent (Cangene) Major Business
Table 25. Emergent (Cangene) Hyper Immune Globulin Product and Services
Table 26. Emergent (Cangene) Hyper Immune Globulin Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Kamada Basic Information, Manufacturing Base and Competitors
Table 28. Kamada Major Business
Table 29. Kamada Hyper Immune Globulin Product and Services
Table 30. Kamada Hyper Immune Globulin Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. CNBG Basic Information, Manufacturing Base and Competitors
Table 32. CNBG Major Business
Table 33. CNBG Hyper Immune Globulin Product and Services
Table 34. CNBG Hyper Immune Globulin Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Hualan Bio Basic Information, Manufacturing Base and Competitors
Table 36. Hualan Bio Major Business
Table 37. Hualan Bio Hyper Immune Globulin Product and Services
Table 38. Hualan Bio Hyper Immune Globulin Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Shanghai RAAS Basic Information, Manufacturing Base and Competitors
Table 40. Shanghai RAAS Major Business
Table 41. Shanghai RAAS Hyper Immune Globulin Product and Services
Table 42. Shanghai RAAS Hyper Immune Globulin Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. Sichuan Yuanda Shuyang Basic Information, Manufacturing Base and Competitors
Table 44. Sichuan Yuanda Shuyang Major Business
Table 45. Sichuan Yuanda Shuyang Hyper Immune Globulin Product and Services
Table 46. Sichuan Yuanda Shuyang Hyper Immune Globulin Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 47. ADMA Biologics Basic Information, Manufacturing Base and Competitors
Table 48. ADMA Biologics Major Business
Table 49. ADMA Biologics Hyper Immune Globulin Product and Services
Table 50. ADMA Biologics Hyper Immune Globulin Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 51. Global Hyper Immune Globulin Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 52. Global Hyper Immune Globulin Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 53. Market Position of Manufacturers in Hyper Immune Globulin, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 54. Global Hyper Immune Globulin Production Capacity by Company, (K Units): 2020 VS 2021
Table 55. Head Office and Hyper Immune Globulin Production Site of Key Manufacturer
Table 56. Hyper Immune Globulin New Entrant and Capacity Expansion Plans
Table 57. Hyper Immune Globulin Mergers & Acquisitions in the Past Five Years
Table 58. Global Hyper Immune Globulin Sales by Region (2017-2022) & (K Units)
Table 59. Global Hyper Immune Globulin Sales by Region (2023-2028) & (K Units)
Table 60. Global Hyper Immune Globulin Revenue by Region (2017-2022) & (USD Million)
Table 61. Global Hyper Immune Globulin Revenue by Region (2023-2028) & (USD Million)
Table 62. Global Hyper Immune Globulin Sales by Type (2017-2022) & (K Units)
Table 63. Global Hyper Immune Globulin Sales by Type (2023-2028) & (K Units)
Table 64. Global Hyper Immune Globulin Revenue by Type (2017-2022) & (USD Million)
Table 65. Global Hyper Immune Globulin Revenue by Type (2023-2028) & (USD Million)
Table 66. Global Hyper Immune Globulin Price by Type (2017-2022) & (US$/Unit)
Table 67. Global Hyper Immune Globulin Price by Type (2023-2028) & (US$/Unit)
Table 68. Global Hyper Immune Globulin Sales by Application (2017-2022) & (K Units)
Table 69. Global Hyper Immune Globulin Sales by Application (2023-2028) & (K Units)
Table 70. Global Hyper Immune Globulin Revenue by Application (2017-2022) & (USD Million)
Table 71. Global Hyper Immune Globulin Revenue by Application (2023-2028) & (USD Million)
Table 72. Global Hyper Immune Globulin Price by Application (2017-2022) & (US$/Unit)
Table 73. Global Hyper Immune Globulin Price by Application (2023-2028) & (US$/Unit)
Table 74. North America Hyper Immune Globulin Sales by Country (2017-2022) & (K Units)
Table 75. North America Hyper Immune Globulin Sales by Country (2023-2028) & (K Units)
Table 76. North America Hyper Immune Globulin Revenue by Country (2017-2022) & (USD Million)
Table 77. North America Hyper Immune Globulin Revenue by Country (2023-2028) & (USD Million)
Table 78. North America Hyper Immune Globulin Sales by Type (2017-2022) & (K Units)
Table 79. North America Hyper Immune Globulin Sales by Type (2023-2028) & (K Units)
Table 80. North America Hyper Immune Globulin Sales by Application (2017-2022) & (K Units)
Table 81. North America Hyper Immune Globulin Sales by Application (2023-2028) & (K Units)
Table 82. Europe Hyper Immune Globulin Sales by Country (2017-2022) & (K Units)
Table 83. Europe Hyper Immune Globulin Sales by Country (2023-2028) & (K Units)
Table 84. Europe Hyper Immune Globulin Revenue by Country (2017-2022) & (USD Million)
Table 85. Europe Hyper Immune Globulin Revenue by Country (2023-2028) & (USD Million)
Table 86. Europe Hyper Immune Globulin Sales by Type (2017-2022) & (K Units)
Table 87. Europe Hyper Immune Globulin Sales by Type (2023-2028) & (K Units)
Table 88. Europe Hyper Immune Globulin Sales by Application (2017-2022) & (K Units)
Table 89. Europe Hyper Immune Globulin Sales by Application (2023-2028) & (K Units)
Table 90. Asia-Pacific Hyper Immune Globulin Sales by Region (2017-2022) & (K Units)
Table 91. Asia-Pacific Hyper Immune Globulin Sales by Region (2023-2028) & (K Units)
Table 92. Asia-Pacific Hyper Immune Globulin Revenue by Region (2017-2022) & (USD Million)
Table 93. Asia-Pacific Hyper Immune Globulin Revenue by Region (2023-2028) & (USD Million)
Table 94. Asia-Pacific Hyper Immune Globulin Sales by Type (2017-2022) & (K Units)
Table 95. Asia-Pacific Hyper Immune Globulin Sales by Type (2023-2028) & (K Units)
Table 96. Asia-Pacific Hyper Immune Globulin Sales by Application (2017-2022) & (K Units)
Table 97. Asia-Pacific Hyper Immune Globulin Sales by Application (2023-2028) & (K Units)
Table 98. South America Hyper Immune Globulin Sales by Country (2017-2022) & (K Units)
Table 99. South America Hyper Immune Globulin Sales by Country (2023-2028) & (K Units)
Table 100. South America Hyper Immune Globulin Revenue by Country (2017-2022) & (USD Million)
Table 101. South America Hyper Immune Globulin Revenue by Country (2023-2028) & (USD Million)
Table 102. South America Hyper Immune Globulin Sales by Type (2017-2022) & (K Units)
Table 103. South America Hyper Immune Globulin Sales by Type (2023-2028) & (K Units)
Table 104. South America Hyper Immune Globulin Sales by Application (2017-2022) & (K Units)
Table 105. South America Hyper Immune Globulin Sales by Application (2023-2028) & (K Units)
Table 106. Middle East & Africa Hyper Immune Globulin Sales by Region (2017-2022) & (K Units)
Table 107. Middle East & Africa Hyper Immune Globulin Sales by Region (2023-2028) & (K Units)
Table 108. Middle East & Africa Hyper Immune Globulin Revenue by Region (2017-2022) & (USD Million)
Table 109. Middle East & Africa Hyper Immune Globulin Revenue by Region (2023-2028) & (USD Million)
Table 110. Middle East & Africa Hyper Immune Globulin Sales by Type (2017-2022) & (K Units)
Table 111. Middle East & Africa Hyper Immune Globulin Sales by Type (2023-2028) & (K Units)
Table 112. Middle East & Africa Hyper Immune Globulin Sales by Application (2017-2022) & (K Units)
Table 113. Middle East & Africa Hyper Immune Globulin Sales by Application (2023-2028) & (K Units)
Table 114. Hyper Immune Globulin Raw Material
Table 115. Key Manufacturers of Hyper Immune Globulin Raw Materials
Table 116. Direct Channel Pros & Cons
Table 117. Indirect Channel Pros & Cons
Table 118. Hyper Immune Globulin Typical Distributors
Table 119. Hyper Immune Globulin Typical Customers
List of Figures
Figure 1. Hyper Immune Globulin Picture
Figure 2. Global Hyper Immune Globulin Revenue Market Share by Type in 2021
Figure 3. Hepatitis B Immunoglobulins
Figure 4. Rabies Immunoglobulins
Figure 5. Tetanus Immunoglobulins
Figure 6. Rho(D) Immunoglobulins
Figure 7. Others
Figure 8. Global Hyper Immune Globulin Revenue Market Share by Application in 2021
Figure 9. Government Institutions
Figure 10. Private Sector
Figure 11. Others
Figure 12. Global Hyper Immune Globulin Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 13. Global Hyper Immune Globulin Revenue and Forecast (2017-2028) & (USD Million)
Figure 14. Global Hyper Immune Globulin Sales (2017-2028) & (K Units)
Figure 15. Global Hyper Immune Globulin Price (2017-2028) & (US$/Unit)
Figure 16. Global Hyper Immune Globulin Production Capacity (2017-2028) & (K Units)
Figure 17. Global Hyper Immune Globulin Production Capacity by Geographic Region: 2022 VS 2028
Figure 18. Hyper Immune Globulin Market Drivers
Figure 19. Hyper Immune Globulin Market Restraints
Figure 20. Hyper Immune Globulin Market Trends
Figure 21. Global Hyper Immune Globulin Sales Market Share by Manufacturer in 2021
Figure 22. Global Hyper Immune Globulin Revenue Market Share by Manufacturer in 2021
Figure 23. Hyper Immune Globulin Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 24. Top 3 Hyper Immune Globulin Manufacturer (Revenue) Market Share in 2021
Figure 25. Top 6 Hyper Immune Globulin Manufacturer (Revenue) Market Share in 2021
Figure 26. Global Hyper Immune Globulin Sales Market Share by Region (2017-2028)
Figure 27. Global Hyper Immune Globulin Revenue Market Share by Region (2017-2028)
Figure 28. North America Hyper Immune Globulin Revenue (2017-2028) & (USD Million)
Figure 29. Europe Hyper Immune Globulin Revenue (2017-2028) & (USD Million)
Figure 30. Asia-Pacific Hyper Immune Globulin Revenue (2017-2028) & (USD Million)
Figure 31. South America Hyper Immune Globulin Revenue (2017-2028) & (USD Million)
Figure 32. Middle East & Africa Hyper Immune Globulin Revenue (2017-2028) & (USD Million)
Figure 33. Global Hyper Immune Globulin Sales Market Share by Type (2017-2028)
Figure 34. Global Hyper Immune Globulin Revenue Market Share by Type (2017-2028)
Figure 35. Global Hyper Immune Globulin Price by Type (2017-2028) & (US$/Unit)
Figure 36. Global Hyper Immune Globulin Sales Market Share by Application (2017-2028)
Figure 37. Global Hyper Immune Globulin Revenue Market Share by Application (2017-2028)
Figure 38. Global Hyper Immune Globulin Price by Application (2017-2028) & (US$/Unit)
Figure 39. North America Hyper Immune Globulin Sales Market Share by Type (2017-2028)
Figure 40. North America Hyper Immune Globulin Sales Market Share by Application (2017-2028)
Figure 41. North America Hyper Immune Globulin Sales Market Share by Country (2017-2028)
Figure 42. North America Hyper Immune Globulin Revenue Market Share by Country (2017-2028)
Figure 43. United States Hyper Immune Globulin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Canada Hyper Immune Globulin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 45. Mexico Hyper Immune Globulin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 46. Europe Hyper Immune Globulin Sales Market Share by Type (2017-2028)
Figure 47. Europe Hyper Immune Globulin Sales Market Share by Application (2017-2028)
Figure 48. Europe Hyper Immune Globulin Sales Market Share by Country (2017-2028)
Figure 49. Europe Hyper Immune Globulin Revenue Market Share by Country (2017-2028)
Figure 50. Germany Hyper Immune Globulin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. France Hyper Immune Globulin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. United Kingdom Hyper Immune Globulin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Russia Hyper Immune Globulin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Italy Hyper Immune Globulin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. Asia-Pacific Hyper Immune Globulin Sales Market Share by Region (2017-2028)
Figure 56. Asia-Pacific Hyper Immune Globulin Sales Market Share by Application (2017-2028)
Figure 57. Asia-Pacific Hyper Immune Globulin Sales Market Share by Region (2017-2028)
Figure 58. Asia-Pacific Hyper Immune Globulin Revenue Market Share by Region (2017-2028)
Figure 59. China Hyper Immune Globulin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Japan Hyper Immune Globulin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Korea Hyper Immune Globulin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. India Hyper Immune Globulin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Southeast Asia Hyper Immune Globulin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. Australia Hyper Immune Globulin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. South America Hyper Immune Globulin Sales Market Share by Type (2017-2028)
Figure 66. South America Hyper Immune Globulin Sales Market Share by Application (2017-2028)
Figure 67. South America Hyper Immune Globulin Sales Market Share by Country (2017-2028)
Figure 68. South America Hyper Immune Globulin Revenue Market Share by Country (2017-2028)
Figure 69. Brazil Hyper Immune Globulin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. Argentina Hyper Immune Globulin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 71. Middle East & Africa Hyper Immune Globulin Sales Market Share by Type (2017-2028)
Figure 72. Middle East & Africa Hyper Immune Globulin Sales Market Share by Application (2017-2028)
Figure 73. Middle East & Africa Hyper Immune Globulin Sales Market Share by Region (2017-2028)
Figure 74. Middle East & Africa Hyper Immune Globulin Revenue Market Share by Region (2017-2028)
Figure 75. Turkey Hyper Immune Globulin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Egypt Hyper Immune Globulin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Saudi Arabia Hyper Immune Globulin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. South Africa Hyper Immune Globulin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 79. Manufacturing Cost Structure Analysis of Hyper Immune Globulin in 2021
Figure 80. Manufacturing Process Analysis of Hyper Immune Globulin
Figure 81. Hyper Immune Globulin Industrial Chain
Figure 82. Sales Channel: Direct Channel vs Indirect Channel
Figure 83. Methodology
Figure 84. Research Process and Data Source


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 免疫グロブリン皮下注射のグローバル市場展望 2023年-2029年：2g、4g、10g、その他
  • 世界の狂犬病免疫グロブリン市場2022年：市場規模予測（～2028年）
  • 世界のヒト狂犬病免疫グロブリン（HRIG）市場2022年：市場規模予測（～2028年）
  • 世界のヒト破傷風免疫グロブリン市場2022年：市場規模予測（～2028年）
  • ヒト破傷風用免疫グロブリンのグローバル市場展望 2023年-2029年：注射剤、フリーズドライ注射剤
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR22NO17909 )"世界のハイパー免疫グロブリン市場2022年：市場規模予測（～2028年）" (英文：Global Hyper Immune Globulin Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。